|
1
|
Tavani A and La Vecchia C: Epidemiology of
renal-cell carcinoma. J Nephrol. 10:93–106. 1997.PubMed/NCBI
|
|
2
|
National Cancer Institute: Surveillance,
Epidemiology, and End Results Program. SEER stat fact sheets:
Kidney and renal pelvis cancer. Available at: http://seer.cancer.gov/statfacts/html/kidrp.html.
Accessed 30, 2014.
|
|
3
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J. 353:2477–2490. 2005. View Article : Google Scholar
|
|
5
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wu Z, Fu X and Han W: Long noncoding
RNAs: Insights from biological features and functions to diseases.
Med Res Rev. 33:517–553. 2013. View Article : Google Scholar
|
|
10
|
Takagi M, Absalon MJ, McLure KG and Kastan
MB: Regulation of p53 translation and induction after DNA damage by
ribosomal protein L26 and nucleolin. Cell. 123:49–63. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of UCA1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Li X, Xie X, Zhao L and Chen W:
UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma
and embryo, influencing cell growth and promoting invasion. FEBS
Lett. 582:1919–1927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie XJ, Li X, Wang F and Chen W: Cellular
localization and tissue expression pattern of UCA1, a non-coding
RNA. Nan Fang Yi Ke Da Xue Xue Bao. 30:57–60. 2010.In Chinese.
PubMed/NCBI
|
|
15
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsang WP, Wong TW, Cheung AH, Co CN and
Kwok TT: Induction of drug resistance and transformation in human
cancer cells by the noncoding RNA CUDR. RNA. 13:890–898. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian Y, Zhang X, Hao Y, Fang Z and He Y:
Potential roles of abnormally expressed long noncoding RNA UCA1 and
Malat-1 in metastasis of melanoma. Melanoma Res. 24:335–341. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han Y, Yang YN, Yuan HH, Zhang TT, Sui H,
Wei XL, Liu L, Huang P, Zhang WJ and Bai YX: UCA1, a long
non-coding RNA up-regulated in colorectal cancer influences cell
proliferation, apoptosis and cell cycle distribution. Pathology.
46:396–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth
by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th edition.
Springer; New York, NY: pp. 479–89. 2010
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Wang T, Yuan J, Feng N, Li Y, Lin Z, Jiang
Z and Gui Y: Hsa-miR-1 downregulates long non-coding RNA urothelial
cancer associated 1 in bladder cancer. Tumour Biol. 35:10075–10084.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar PP, Emechebe U, Smith R, Franklin S,
Moore B, Yandell M, Lessnick SL and Moon AM: Coordinated control of
senescence by lncRNA and a novel T-box3 co-repressor complex.
Elife. 3:e028052014. View Article : Google Scholar
|
|
28
|
Yang L, Froberg JE and Lee JT: Long
noncoding RNAs: Fresh perspectives into the RNA world. Trends
Biochem Sci. 39:35–43. 2014. View Article : Google Scholar :
|
|
29
|
Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X
and Li X: Long non-coding RNA UCA1a(CUDR) promotes proliferation
and tumorigenesis of bladder cancer. Int J Oncol. 41:276–284.
2012.PubMed/NCBI
|
|
30
|
Xue M, Li X, Wu W, Zhang S, Wu S, Li Z and
Chen W: Upregulation of long non-coding RNA urothelial carcinoma
associated 1 by CCAAT/enhancer binding protein α contributes to
bladder cancer cell growth and reduced apoptosis. Oncol Rep.
31:1993–2000. 2014.PubMed/NCBI
|
|
31
|
Xue M, Li X, Li Z and Chen W: Urothelial
carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted
long noncoding RNA that enhances hypoxic bladder cancer cell
proliferation, migration, and invasion. Tumour Biol. 35:6901–6912.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu W, Zhang S, Li X, Xue M, Cao S and Chen
W: Ets-2 regulates cell apoptosis via the Akt pathway, through the
regulation of urothelial cancer associated 1, a long non-coding
RNA, in bladder cancer cells. PLoS One. 820132013.
|
|
34
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Srivastava AK, Singh PK, Rath SK, Dalela
D, Goel MM and Bhatt ML: Appraisal of diagnostic ability of UCA1 as
a biomarker of carcinoma of the urinary bladder. Tumour Biol.
35:11435–11442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Z, Hao H, Zhang CJ, Yang XY, He Q
and Lin J: Evaluation of novel gene UCA1 as a tumor biomarker for
the detection of bladder cancer. Zhonghua Yi Xue Za Zhi.
92:384–387. 2012.In Chinese. PubMed/NCBI
|
